Treatment Options for Patients with Non-Small Cell Lung Cancer and Liver Metastases

Treatment Options for Patients with Non-Small Cell Lung Cancer and Liver Metastases

Lung cancer represents the most common cause of cancer-related death. Patients with non-small cell lung cancer (NSCLC) and liver metastases have worse prognosis, with an overall survival (OS) from three to six months. The majority of them have a poor response to chemotherapy, and the data are contro...

Full description

Saved in:
Bibliographic Details
Main Authors: Vesna Ćeriman Krstić, Natalija Samardžić, Milija Gajić, Milan Savić, Biljana Šeha, Marina Roksandić Milenković, Dragana Jovanović
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Current Issues in Molecular Biology
Subjects:
NSCLC
liver metastases
immunotherapy
combination therapies
radiotherapy
surgery
Online Access:https://www.mdpi.com/1467-3045/46/12/802
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1467-3045/46/12/802

Similar Items